Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • ELECTRONIC HEALTH RECORDS—7th Cir.: Court remands consolidated hospital privacy breach lawsuit back to state court
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Inadvertent omission of ‘medical director’ information on revalidation application grounds for enrollment and billing revocation, 10-year re-enrollment bar
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ADVERTISING (FOOD, DRUG & MEDICAL DEVICES)—N.D. Cal.: Henry Meds must collect ESI from cloud-based platforms
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CIVIL MONEY PENALTIES—NOTICES: No Adjustment to HHS Civil Monetary Penalty Amounts for 2026
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • DRUGS AND BIOLOGICS—NOTICES: Electronic Common Technical Document (eCTD); Data Standards; Supporting Forward Compatibility for eCTD 4.0
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • END-STAGE RENAL DISEASE—OTHER AGENCY DOCUMENTS: HHS Kidney Care National Plan calls for competition, prevention, and transplant reform
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—FinCEN Targets $17.5 Billion In Suspected Health Care Fraud
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ORGAN PROCUREMENT AND TRANSPLANTATION—OTHER AGENCY DOCUMENTS: ASPE data brief shows health and economic benefits associated with increased kidney transplantation
    • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRESCRIPTION DRUGS—FDA GUIDANCE NOTICES: Regulatory Considerations for Prescription Drug Use-Related Software; Guidance for Industry; Availability
    • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS—DAB DECISIONS: Inadvertent omission of ‘medical director’ information on revalidation application grounds for enrollment and billing revocation, 10-year re-enrollment bar, (Oct 22, 2026)

    By Jeffrey H. Brochin, J.D.

    The plain language of 42 C.F.R. §424.535(a)(4) does not require any intent to deceive, rather it simply states that CMS may revoke when a provider “certified as ‘true’ misleading or false information on the enrollment application ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use